GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anhui Anke Biotechnology (Group) Co Ltd (SZSE:300009) » Definitions » Sale Of Investment

Anhui Anke Biotechnology (Group) Co (SZSE:300009) Sale Of Investment : ¥1,013 Mil (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Anhui Anke Biotechnology (Group) Co Sale Of Investment?

Anhui Anke Biotechnology (Group) Co's sale of investment for the three months ended in Mar. 2024 was ¥894 Mil. It means Anhui Anke Biotechnology (Group) Co gained ¥894 Mil from selling investments. Anhui Anke Biotechnology (Group) Co's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,013 Mil.

Compared with last quarter (¥132 Mil in Dec. 2023 ), Anhui Anke Biotechnology (Group) Co gained more money from selling investments in Mar. 2024 (¥894 Mil).


Anhui Anke Biotechnology (Group) Co Sale Of Investment Historical Data

The historical data trend for Anhui Anke Biotechnology (Group) Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Anke Biotechnology (Group) Co Sale Of Investment Chart

Anhui Anke Biotechnology (Group) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.20 508.42 742.90 822.17 864.90

Anhui Anke Biotechnology (Group) Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 745.40 13.06 -25.77 132.20 893.59

Anhui Anke Biotechnology (Group) Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,013 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anhui Anke Biotechnology (Group) Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Anhui Anke Biotechnology (Group) Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Anhui Anke Biotechnology (Group) Co (SZSE:300009) Business Description

Traded in Other Exchanges
N/A
Address
No.9 Changjiang Road, Hefei High-tech Zone, Customs Road 669, Hefei, CHN, 230088
Anhui Anke Biotechnology (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceuticals and health-care products. The Company distributes its product in both domestic and overseas markets. The company operates in more than 30 provinces in China.
Executives
Zhou Yuan Yuan Directors, executives
Wang Yong Supervisors
Yao Jian Ping Executives
Wang Rong Hai Directors, executives
Song She Wu Directors, executives
Fu Yong Biao Directors, executives
Jiang Jun Pei Supervisors
Zhao Hui Directors, executives
Xu Zhen Shan Director
Lu Guang Xin Executives
Yan Xin Wen Executives
Lu Chun Yan Executives
Wu Rui Director
Fan Qing Lin Director
Wang Yong Bin Executives

Anhui Anke Biotechnology (Group) Co (SZSE:300009) Headlines

No Headlines